Comparison of potential cost of palivizumab administration with actual cost of hospitalisation for RSV positive or RSV unknown LRTI
| Treatment category | Number of infants | Cost of prophylaxis | Number of admissions | Hospitalisation cost |
| 1. Infants <2 y with CLD on home oxygen | 8 | £33 888 | 1 | £30 072 |
| 2. Infants <2 y with CLD who have stopped oxygen in prior 6 months | 31 | £131 316 | 4 | £13 644 |
| 3. Infants <1 y born at <29 weeks gestation | 7 | £29 652 | 0 | £0 |
| 4. Infants <6 months born at 29–32 weeks gestation | 41 | £173 676 | 1 | £472 |
| All | 87 | £368 532 | 6 | £44 188 |